PTG-300-11
Clinical Trial Grant
Awarded By
Protagonist Therapeutics Inc.
Start Date
July 26, 2022
End Date
July 31, 2027
Awarded By
Protagonist Therapeutics Inc.
Start Date
July 26, 2022
End Date
July 31, 2027